Skip to content

California and Florida vape directories: what a listing does—and does not—prove

Also in Market Access

Summary: California’s Unflavored Tobacco List and Florida’s directory of nicotine devices attractive to minors answer different questions. For vaping suppliers and retailers, a useful directory check starts with the product definition, the exact entry and the business activity—not an assumption that either state operates a universal whitelist.

Official materials examined on 19 November 2026. This comparison concerns selected California and Florida directory rules for vaping supply chains, not the current listing or lawful sale of any particular product, a shipment decision, or a complete guide to either state.

A supplier’s statement that a vape is “on the state list” is incomplete. Which list? Which product and packaging? Is inclusion a condition for sale, or does it identify a product for removal? California and Florida provide a particularly important contrast: the same word, directory, can point in opposite directions. California DOJ describes the UTL as a list on which a covered product must appear; Florida’s statute creates a directory of nicotine dispensing devices deemed attractive to minors, with inventory-removal and sales restrictions. 1 7 8

Question California UTL Florida minors-attractive directory
What does inclusion address? A particular covered Brand Style’s placement on the unflavored list, under the state’s application rules. Identification under a statutory mechanism for devices deemed attractive to minors—not a list of approved devices.
What does absence establish? For a covered product, absence is not neutral: DOJ says it is treated as a prohibited flavored product. First establish whether the product falls within the UTL’s scope or an exemption. Absence alone does not establish FDA marketing status, a dealer’s permit, or compliance with other requirements.
Is this a universal permission to sell? No: the state’s own rules separately address FDA status, and licensing, tax and destination questions remain distinct. No: the directory provision has its own product limits and exceptions, while federal and dealer requirements are separate.

These distinctions come from the different listing provisions, not from a ranking of one state as more permissive than the other. 1 4 7 8 9 10 13

California: a product-specific unflavored-list requirement

The DOJ’s UTL guide describes specific Brand Styles that manufacturers and importers have certified, under penalty of perjury, as containing no constituents that impart a characterizing flavor. It says a covered tobacco product must be included to be sold legally in California; otherwise it is classified as a prohibited flavored tobacco product under Health and Safety Code §§104559.1(g) and 104559.5(a)(6). That is a condition within the covered-product framework, not proof that every other condition for trade has been satisfied. 1

The application rules reinforce the product-level distinction. An applicant is a manufacturer or importer, and §947(e) requires a completed, approved application for each Brand Style, even if similar Brand Styles are already listed. A manufacturer’s presence or a near-match in a trade name is therefore not a substitute for checking the relevant product entry. 4 (§§942(a), 947(c), (e))

Match the definition before interpreting the result

The UTL guide describes two categories: products containing or derived from tobacco or nicotine—including synthetic nicotine, nicotinic alkaloids and nicotine analogs—intended for human consumption; and electronic delivery systems that deliver nicotine or vaporized liquids to the user. It expressly says devices “sold without nicotine or liquid” are not covered by the UTL. The guide also identifies exemptions for shisha, looseleaf pipe tobacco and qualifying premium cigars, with conditions: flavored shisha’s exemption is partial and tied to licensed, age-restricted retailers. These are not general exemptions for vaping products. 1

An exclusion from the list’s coverage must not be carried over to every other California rule. DOJ’s separate flavor-ban bulletin addresses non-nicotine e-cigarettes and describes limited FDA-approved nicotine-replacement and cannabis exclusions, including a tobacco/nicotine-ingredient qualification for cannabis products. A “zero nicotine” label is not, by itself, an answer to all these definitions. 5 (pp.1–2)

A UTL entry is not an FDA marketing order

California does not ignore federal product status. Section 948 begins by making a Brand Style that requires federal premarket authorization but has not received it ineligible for listing, unless specified conditions apply. Those provisions include defined application histories and certain stayed, rescinded or vacated negative actions; §948(b) addresses further demonstrations concerning federal authorization requirements and application status. Section 948(c) separately addresses a defined Variant of a listed Predicate Brand Style where the specified variant form has been submitted. These provisions do not say that every pending PMTA qualifies. 4 (§948(a)–(c), pp.18–19)

The important distinction is between California’s criteria for state listing and the federal decision itself. Even where the state’s exception criteria are met, a UTL entry is not the FDA order. Section 910 of the federal tobacco statute sets out premarket-review requirements, routes and exceptions separately. FDA also distinguishes “authorized” products from the expression “FDA approved.” Product-specific federal evidence must be examined on its own terms. 4 12 14

Florida: identification for removal, not a sales whitelist

Florida Statutes §569.311 says the mechanism is intended to let the state seek removal of devices that present a greater attraction to minors. The Attorney General must include a device where its features are significantly appealing to minors compared with their legitimate benefits to lawful users, applying the statutory considerations. Those considerations include design, concealability, marketing and food-product imagery, as well as other specified evidence. Subsection (9) describes a directory of manufacturers selling devices deemed attractive to minors; the sales and inventory provisions concern identified devices, not a general endorsement of a manufacturer. This is a different question from California’s unflavored-list application. 7 (subsections (1)–(4), (9)–(11))8

A timely filed PMTA is one consideration under §569.311(3)(e); it is not itself an FDA authorization. Separately, subsection (7) excludes a device that has received a marketing-granted order under 21 U.S.C. §387j from this section. That exclusion is not a statement that every other Florida or federal requirement disappears. 7 (subsections (3)(e), (7))12

The device and system limits matter

Section 569.31(4) defines a nicotine dispensing device by reference to producing vapor or aerosol from a nicotine product, includes specified cartridges and containers of nicotine, and treats each individual SKU as a separate device for that definition. “Nicotine product” has its own definition and exclusions for specified tobacco products, FDA-regulated drugs/devices and incidental nicotine. Do not substitute California’s product definition for Florida’s. 9 (subsections (4)–(5))

The directory section is further limited by §569.311(8): it applies to single-use or disposable devices intended to be discarded, or devices using sealed, prefilled, disposable nicotine cartridges. It excludes the specified open systems in which the consumer fills the container with nicotine solution. An open-system exclusion from §569.311 is not a blanket exemption from regulation, nor does the section supply a universal answer for every zero-nicotine or empty-hardware configuration. 7 (subsection (8))9

Read the inventory clock alongside the shipment rule

For a device added to the directory, §569.311(10) gives retailers and wholesalers holding it for eventual sale to a Florida consumer 60 days from its addition to sell it or remove it from inventory; after that period the identified product is contraband. Subsection (11) separately addresses the initial directory publication, distinguishing retailers’ pre-existing stock from distributors’ and wholesalers’ removal obligations. The manufacturer-penalty provision uses 1 March 2025 or actual first publication, whichever is later, subject to its stated exceptions. These are different triggers, not one universal “60 days from today” rule. 7 (subsections (10)–(11))

Section 569.312(1) separately prohibits a nicotine product manufacturer, retail nicotine products dealer, wholesaler or distributor from selling, shipping or otherwise distributing a listed device in the state for eventual retail sale to a consumer there. A procurement assessment needs both provisions and the relevant dates; it should not turn the inventory language into an assumed blanket permission for new shipments. This comparison does not decide an individual transaction’s timing. 8 7

Keep the dates—and the other regulatory layers—separate

California DOJ describes AB3218’s changes as taking effect on 1 January 2025, with the statute requiring the UTL to be established by 31 December 2025. Its rulemaking index reports that permanent regulations were approved and filed on 19 June 2026, corroborated by OAL’s approval letter. The latter is a rulemaking milestone, not a new commencement date for every flavor restriction or proof of the list’s actual first-publication day. 2 3

Florida’s statute specifies 1 January 2025 for directory availability; its official rule index lists 28 January 2025 as the effective date of Rule 2-4.001. Neither date should be substituted for a particular product’s addition date or an actual first-publication date when applying the inventory provisions. The index also lists later rule-development activity; a development or workshop notice is not, by itself, an adopted amendment. 7 (subsections (9)–(11))11

Business permissions and tax rules answer further questions. California CDTFA says retail sales of products such as 0mg nicotine liquids or electronic cigarettes sold without nicotine still require a cigarette and tobacco products retailer licence. Its CECET guidance separately distinguishes nicotine-containing or nicotine-bundled sales from specified standalone or zero-nicotine devices. A tax-scope exclusion is not a UTL determination or a retailer-licensing exemption. 6 15

Florida §569.32 requires the relevant retail nicotine dealer permit for each place where nicotine products are sold and limits a permit to the named person and designated place. A directory entry does not identify every business entitled to handle the product. This is a selected retail example, not a complete manufacturer, wholesaler, remote-sales or tax checklist. 10

The federal boundary is also qualified, not absolute. Section 916 preserves specified state, local and tribal authority and taxation, while also preempting certain state/local requirements and setting exceptions for matters including sales and distribution. It is not a basis for assuming that FDA status settles every destination requirement—or that every conceivable state rule is necessarily valid. This article does not adjudicate a preemption dispute or survey all local laws. 13

What to ask for in a supply-chain review

The practical lesson is to separate the evidence rather than seek one conclusive certificate:

  • Product identity: the exact Brand Style or SKU, configuration, liquid/nicotine facts and the definition being applied—not merely the company name.
  • Directory evidence: which state mechanism, the matching entry and relevant dates, and any applicable exception or removal history.
  • Federal evidence: the actual decision or other applicable statutory basis for the product, not a state listing or an application identifier alone.
  • Business and destination evidence: the actual seller’s role, required permissions and applicable tax/channel rules, assessed separately from product-list status.

These are evidence questions drawn from the provisions above, not an alternative approval procedure. VapeVisa’s [classification, operating-role and FDA-registration guide, published 19 November 2026] 16, explains why registration is not product authorization. Its [US import-evidence guide, also published 19 November 2026] 17, separates product records from entry and shipment decisions. This state-directory comparison adds another layer; it does not replace those checks or extend either guide into a guarantee of sale.

No individual product’s current listing, exemption, litigation status or lawful sale is determined here. The sources are selected official materials—not a complete account of subsequent litigation, every state amendment or all local requirements. The federal statutory text examined includes laws through 10 November 2026; the Florida pages display the 2026 Statutes. Those publication cutoffs and the examination date are not new legal effective dates.

Official sources and related reporting

Information for business research, not legal advice, a product recommendation or a product/shipment guarantee. No continuing monitoring is promised.